Related Experiment Video

Updated: Jun 3, 2026

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

Blockade of T-type Ca(2+) channels inhibits human ovarian cancer cell proliferation

Wei Li1, Shu-Lan Zhang, Ning Wang

  • 1Department of Gynecology, Shengjing Hospital, China Medical University, Shenyang, China.

Cancer Investigation
|March 29, 2011
PubMed

Insights

T-type calcium channels are upregulated in ovarian cancer. Blocking these channels, or their specific protein expression, suppressed cancer cell proliferation and tumor formation, highlighting their critical role in ovarian cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Calcium (Ca2+) channels play a role in tumor cell progression.
  • T-type Ca2+ channels are increasingly recognized for their involvement in various cancers.

Purpose of the Study:

  • To investigate the role of T-type Ca2+ channels in human ovarian cancer.
  • To determine if T-type Ca2+ channel blockade affects ovarian cancer cell proliferation and tumor formation.

Main Methods:

  • Quantitative analysis of T-type Ca2+ channel expression in human ovarian cancer tissues versus normal tissues.
  • Pharmacological blockade of T-type Ca2+ channels using NNC 55-0396 and mibefradil.
  • Gene silencing of T-type Ca2+ channel subunits (Ca_v3.1/3.2) using siRNA.
  • Assessment of ovarian cancer cell proliferation and cell cycle distribution (G0/G1 phase).
  • In vivo studies using nude mice to evaluate the effect of NNC 55-0396 on ovarian cancer formation.

Main Results:

  • T-type Ca2+ channel expression is significantly elevated in human ovarian cancer tissues compared to normal ovarian tissues.
  • Pharmacological blockade and siRNA-mediated knockdown of T-type Ca2+ channels suppressed the proliferation of ovarian cancer cell lines.
  • Inhibition of T-type Ca2+ channels led to an increased G0/G1 phase distribution in the cell cycle of ovarian cancer cells.
  • Treatment with NNC 55-0396 significantly slowed ovarian cancer formation in a nude mouse model.

Conclusions:

  • T-type Ca2+ channels are upregulated in human ovarian cancer and are crucial for cancer cell proliferation.
  • Targeting T-type Ca2+ channels represents a potential therapeutic strategy for ovarian cancer.

More Related Videos

Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity09:00

Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity

Published on: December 31, 2015

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time14:25

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time

Published on: May 20, 2014

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...